Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Raitses-Gurevich

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer Medicine|September 12, 2024
Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinomaDoron Yablecovitch, Moshe Nadler, Shomron Ben-Horin, et al.
International Journal of Cancer|June 16, 2026
Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE ConsortiumChristine Worthington, Maria Raitses-Gurevich, Giulio Innamorati, et al.
Oncotarget|May 11, 2017
Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant diseaseTalia Golan, Chani Stossel, Michael Schvimer, et al.
International Journal of Cancer|February 4, 2018
Recapitulating the clinical scenario of BRCA-associated pancreatic cancer in pre-clinical modelsTalia Golan, Chani Stossel, Dikla Atias, et al.
Nature|March 23, 2023
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancerAmina Jbara, Kuan-Ting Lin, Chani Stossel, et al.
Cancer|October 20, 2023
The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variantsIdo Laish, Menachem Schechter, Alain Dancour, et al.
Cancer Research|July 6, 2019
Poly (ADP) Ribose Glycohydrolase Can Be Effectively Targeted in Pancreatic CancerAditi Jain, Lebaron C Agostini, Grace A McCarthy, et al.
Nature|May 31, 2023
Hallmarks of transcriptional intratumour heterogeneity across a thousand tumoursAvishai Gavish, Michael Tyler, Alissa C Greenwald, et al.
Cancer Discovery|July 14, 2023
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical SettingChani Stossel, Maria Raitses-Gurevich, Dikla Atias, et al.
Gastroenterology|February 1, 2021
Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal AdenocarcinomaTalia Golan, Grainne M O'Kane, Robert E Denroche, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Medicine|September 12, 2024
Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinomaDoron Yablecovitch, Moshe Nadler, Shomron Ben-Horin, et al.
International Journal of Cancer|June 16, 2026
Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE ConsortiumChristine Worthington, Maria Raitses-Gurevich, Giulio Innamorati, et al.
Oncotarget|May 11, 2017
Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant diseaseTalia Golan, Chani Stossel, Michael Schvimer, et al.
International Journal of Cancer|February 4, 2018
Recapitulating the clinical scenario of BRCA-associated pancreatic cancer in pre-clinical modelsTalia Golan, Chani Stossel, Dikla Atias, et al.
Nature|March 23, 2023
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancerAmina Jbara, Kuan-Ting Lin, Chani Stossel, et al.
Cancer|October 20, 2023
The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variantsIdo Laish, Menachem Schechter, Alain Dancour, et al.
Cancer Research|July 6, 2019
Poly (ADP) Ribose Glycohydrolase Can Be Effectively Targeted in Pancreatic CancerAditi Jain, Lebaron C Agostini, Grace A McCarthy, et al.
Nature|May 31, 2023
Hallmarks of transcriptional intratumour heterogeneity across a thousand tumoursAvishai Gavish, Michael Tyler, Alissa C Greenwald, et al.
Cancer Discovery|July 14, 2023
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical SettingChani Stossel, Maria Raitses-Gurevich, Dikla Atias, et al.
Gastroenterology|February 1, 2021
Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal AdenocarcinomaTalia Golan, Grainne M O'Kane, Robert E Denroche, et al.
Pageof 3